SHARECARE INC (SHCR) Fundamental Analysis & Valuation
NASDAQ:SHCR • US81948W1045
Current stock price
1.43 USD
-0.01 (-0.35%)
At close:
1.43 USD
0 (0%)
After Hours:
This SHCR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SHCR Profitability Analysis
1.1 Basic Checks
- In the past year SHCR has reported negative net income.
- SHCR had a negative operating cash flow in the past year.
- In the past 5 years SHCR always reported negative net income.
- In multiple years SHCR reported negative operating cash flow during the last 5 years.
1.2 Ratios
- SHCR has a Return On Assets (-24.25%) which is in line with its industry peers.
- SHCR has a Return On Equity of -31.01%. This is comparable to the rest of the industry: SHCR outperforms 59.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.25% | ||
| ROE | -31.01% | ||
| ROIC | N/A |
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SHCR has a worse Gross Margin (44.04%) than 67.57% of its industry peers.
- SHCR's Gross Margin has declined in the last couple of years.
- SHCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
2. SHCR Health Analysis
2.1 Basic Checks
- SHCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for SHCR has been reduced compared to 1 year ago.
- SHCR has a worse debt/assets ratio than last year.
2.2 Solvency
- SHCR has an Altman-Z score of 0.73. This is a bad value and indicates that SHCR is not financially healthy and even has some risk of bankruptcy.
- SHCR has a Altman-Z score (0.73) which is comparable to the rest of the industry.
- There is no outstanding debt for SHCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.73 |
ROIC/WACCN/A
WACC9.12%
2.3 Liquidity
- SHCR has a Current Ratio of 2.02. This indicates that SHCR is financially healthy and has no problem in meeting its short term obligations.
- SHCR has a Current ratio (2.02) which is comparable to the rest of the industry.
- A Quick Ratio of 2.02 indicates that SHCR has no problem at all paying its short term obligations.
- SHCR has a Quick ratio (2.02) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 2.02 |
3. SHCR Growth Analysis
3.1 Past
- SHCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.43%.
- Looking at the last year, SHCR shows a very negative growth in Revenue. The Revenue has decreased by -13.11% in the last year.
- The Revenue has been growing by 10.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%
3.2 Future
- The Earnings Per Share is expected to grow by 11.33% on average over the next years. This is quite good.
- SHCR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.95% yearly.
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. SHCR Valuation Analysis
4.1 Price/Earnings Ratio
- SHCR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year SHCR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.49%
EPS Next 3Y11.33%
5. SHCR Dividend Analysis
5.1 Amount
- SHCR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SHCR Fundamentals: All Metrics, Ratios and Statistics
1.43
-0.01 (-0.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-09 2024-08-09/bmo
Earnings (Next)11-07 2024-11-07/bmo
Inst Owners38.79%
Inst Owner Change0%
Ins Owners0.1%
Ins Owner Change0%
Market Cap531.79M
Revenue(TTM)403.70M
Net Income(TTM)-135.87M
Analysts48.89
Price Target1.46 (2.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.56%
Min EPS beat(2)-68.07%
Max EPS beat(2)-47.05%
EPS beat(4)1
Avg EPS beat(4)-39.36%
Min EPS beat(4)-68.07%
Max EPS beat(4)8.5%
EPS beat(8)1
Avg EPS beat(8)-38.89%
EPS beat(12)2
Avg EPS beat(12)-55.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.26%
Min Revenue beat(2)-12.09%
Max Revenue beat(2)-2.43%
Revenue beat(4)0
Avg Revenue beat(4)-6.75%
Min Revenue beat(4)-12.09%
Max Revenue beat(4)-2.22%
Revenue beat(8)3
Avg Revenue beat(8)-2.77%
Revenue beat(12)5
Avg Revenue beat(12)-2.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.32 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.21 | ||
| P/tB | 4.32 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS1.09
BVpS1.18
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.25% | ||
| ROE | -31.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.04% | ||
| FCFM | N/A |
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.08% | ||
| Cap/Sales | 0.17% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | 0.73 |
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)6.08%
Cap/Depr(5y)6.54%
Cap/Sales(3y)0.6%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A
EBIT growth 1Y-15.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.69%
EBIT Next 3Y30.06%
EBIT Next 5YN/A
FCF growth 1Y82.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.64%
OCF growth 3YN/A
OCF growth 5YN/A
SHARECARE INC / SHCR Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for SHARECARE INC?
ChartMill assigns a fundamental rating of 3 / 10 to SHCR.
Can you provide the valuation status for SHARECARE INC?
ChartMill assigns a valuation rating of 0 / 10 to SHARECARE INC (SHCR). This can be considered as Overvalued.
Can you provide the profitability details for SHARECARE INC?
SHARECARE INC (SHCR) has a profitability rating of 1 / 10.
What is the expected EPS growth for SHARECARE INC (SHCR) stock?
The Earnings per Share (EPS) of SHARECARE INC (SHCR) is expected to grow by 4.89% in the next year.